Andreas has during the last 7 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.
andreas.gerward@stayble.se+46 (0)730 808 397
General Meetings
General annual meeting regarding financial year 2019 will be held on the 8th of May 2020 in Gothenburg.
IR Contact
M. Sc, CEO.Andreas Gerward
Andreas has during the last 7 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.
andreas.gerward@stayble.se+46 (0)730 808 397
We use cookies to improve the user experience on Stayble Therapeutics. Read more about Cookies